Study finds flaws in cancer clinical trials

Cancer research and drug development are yielding more sophisticated candidate therapies, but investigators' methods to test them haven't kept pace, according to researchers at Memorial Sloan-Kettering Cancer Center. That could explain why so many experimental drugs fail in the final large and costly phase of testing, they say.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news89524526.html">Study finds flaws in cancer clinical trials</a></p> <p>Cancer research and drug development are yielding more sophisticated candidate therapies, but investigators' methods to test them haven't kept pace, according to researchers at Memorial Sloan-Kettering Cancer Center. That could explain why so many experimental drugs fail in the final large and costly phase of testing, they say.</p>